Although compounded drugs are permitted to be prescribed under federal law, they are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
Furthermore, future research should prioritize large-scale, long-term randomized controlled trials to definitively establish optimal dosing regimens, confirm sustained efficacy across diverse PCOS phenotypesespecially considering inherent heterogeneity and ethnic variations, and rigorously evaluate hard clinical endpoints such as live birth rates, prevention of T2D/cardiovascular events, and endometrial cancer risk reduction
While no approved protocol currently exists for this specific combination, the underlying science suggests that multi-pathway approaches targeting amylin, GIP, and GLP-1 receptors simultaneously may offer superior metabolic benefits compared to single-pathway interventions
Inhibition of endocytosis with dynasore blocked both VEGFR2 internalization and the pro-angiogenic effects of BPC 157, confirming the essential role of this process
REQUEST AN APPOINTMENT Consultation Required
